Kudarat, Uting Y.
HRN: 14-80-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2024
CEFTAZIDIME 1GM (VIAL)
02/19/2024
02/26/2024
IV
1g
Every 8 Hours
DM Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes